Here, the very same HLA DQA1 allele is associated with peanut allergy in population cross-sectional studies and with protection from peanut allergy in the LEAP peanut oral prevention trial, where the age at intervention was <11 months, consistent with the concept that mode of exposure distinguishes between sensitization and tolerance outcomes. Here, HLA-DQA2 is linked to peanut allergic reaction.